Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1995-04-14
1999-02-09
Eisenschenk, Frank C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241531, 4351721, 5303873, 53038815, 5303887, 5303911, A61K 39395, C12N 1513, C12P 2108, C07K 1628
Patent
active
058690468
ABSTRACT:
Polypeptides that are cleared from the kidney and do not contain in their original form a Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.
REFERENCES:
patent: 5475091 (1995-12-01), Springer et al.
patent: 5489533 (1996-02-01), Springer et al.
Diegel, M. et al. AIDS Research and Human Retroviruses 9:465-473, May 1993.
Traunecker, A. et al., "Bispecific Single Chain Molecules (Janusins) Target Cytotoxic Lymphocytes on HIV Infected Cells," EMBO J., 10(12):3655-3659 (1991).
Batra, J.K. et al., "Insertion of constant Region Domains of Human IgG.sub.1 Into CD4-PE40 Increases Its Plasma Half-Life," Molecular Immunology, 30(4):379-386 (1993).
Kim, J.-K. Et al., "Catabolism of the Murine IgG1 Molecule: Evidence that Both CH2-CH3 Domain Interfaces are Required for Persistence of IgG1 in the Circulation of Mice," Scand. J. Immunol., 40:457-465 (1994).
Brambell, "The Transmission of Immunity from Mother to Young and the Catabolism of Immunoglobulins" Lancet pp. 1087-1093 (Nov. 19, 1966).
Brambell et al., "A Theoretical Model of .gamma.-Globulin Catabolism" Nature 203:1352-1355 (1964).
Deisenhofer, "Crystallographic Refinement and Atomic Models of a Human Fc fragment and Its complex with Fragment B of Protein A from Staphylococcus aureus at 2.9-and 2.8-A Resolution" Biochemistry 20(9):2361-2370 (1981).
Dima et al., "Effect of protein A and its fragment B on the catabolic and Fc receptor sites of IgG" European Journal of Immunology 13:605-614 (1983).
Ellerson et al., "Isolation and Characterization of a Fragment Corresponding to the C.gamma. Homology Region of Human Immunoglobin G.sup.1." Journal of Immunology 116(2):510-517 (Feb. 1976).
Kim et al., "Identifying amino acid residues that influence plasma clearance of murine IgGa fragments by site-directed mutagenesis" European Journal of Immunology 24:542-548 (1994).
Knauff et al., "Relationship of Effective Molecular Size to Systematic Clearance in Rats of Recombinant Interleukin-2 Chemically Modified with Water-soluable Polymers" Journal of Biological Chemistry 263:15064-15070 (1988).
Masson, "Elimination of Infectious Antigens and Increase of IgG Catabolism as Possible Modes of Action of IVIg" Journal of Autoimmunity 6:683-689 (1993).
Nose et al., "Biological significance of carbohydrate chains on monoclonal antibodies" Proc. Natl. Acad. Sci. USA 80:6632-6636 (Nov. 1983).
Pollock et al., "Intravascular metabolism of normal and mutant mouse immunoglobulin molecules" European Journal of Immunology 20:2021-2027 (1990).
Spector, "The reabsorption of labelled proteins by the normal and nephrotic rat kidney" J. Path. Bact. 68:187-196 (1954).
Spiegelberg, "Biological Activities of Immunoglobulins of Different Classes and Subclasses" Advances in Immunology 19:259-294 (1974).
Spiegelberg et al., "The Catabolism of Homologous and Heterologous 75 Gamma Globulin Fragments" J. of Experimental Medicine, Dubos et al. vol. 121(1):323-338 (1965).
Tao et al., "Role of Carbohydrate in the Structure and Effector Functions Mediated by the Human IgG Constant Region" Journal of Immunology 143(8):2595-2601 (Oct. 15, 1989).
Waldmann et al., "Catabolism of Immunoglobulins" Progress in Immunology 1:1187-1191 (1971).
Wawrzynczak et al., "Blood Clearance in the Rat of a Recombinant Mouse Monoclonal Antibody lacking the N-Linked Oligosaccharide Side Chains of the C.sub.H 2 Domains" Molecular Immunology 29(2):213-220 (1992).
Warzynczak et al., "Recombinant Mouse Monoclonal Antibodies with single Amino Acid SubstitutionsAffecting C1q and High Affinity Fc Receptor Binding Have Identical Serum Half-lives in the BALB/c Mouse" Molecular Immunology 29(2):221-227 (1992).
Wochner et al., "The Role of the Kidney in the Catabolism of Bence Jones Proteins and Immunoglobulin Fragments" Journal of Experimental Medicine 126(2):207-221 (Aug. 1, 1967).
Yasmeen et al., "The Distribution of effector Functions Among the C.gamma.2 and C.gamma.3 Homology Region Immunoglobulin G.sup.1 " Journal of Immunology 116(2):518-526 (Feb. 1976).
Zuckier et al., "Immunologic and Pharmacologic Concepts of Monoclonal Antibodies" Seminars in Nuclear Medicine 19(3):166-186 (Jul. 1989).
Zuckier et al., "The use of Severe Combined Immunodeficiency Mice to Study the Metabolism of Human Immunoglobulin G" Cancer Supplement 73(3):794-799 (Feb. 1, 1994).
Presta Leonard G.
Snedecor Bradley R.
Dreger Walter H.
Eisenschenk Frank C.
Genentech Inc.
Rabin Evelyn
LandOfFree
Altered polypeptides with increased half-life does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Altered polypeptides with increased half-life, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Altered polypeptides with increased half-life will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1946651